{"Welcome.html": {"id": "Welcome.html", "text": "Welcome", "displayed_text": "Welcome"}, "Task.html": {"id": "Task.html", "text": "Task", "displayed_text": "Task"}, "ChangeTypes.html": {"id": "ChangeTypes.html", "text": "ChangeTypes", "displayed_text": "ChangeTypes"}, "Consent.html": {"id": "Consent.html", "text": "Consent", "displayed_text": "Consent"}, "Navigation.html": {"id": "Navigation.html", "text": "Navigation", "displayed_text": "Navigation"}, "Medicine_tweet_183": {"DOI": "10.1001/jamapsychiatry.2015.0500", "id": "Medicine_tweet_183", "News Finding": "Use of #antipsychotic meds increased among teens &amp; young adults from 2006-2010 but not among kids 12 or younger. ", "Paper Finding": "This age profile refines earlier reports of steadily increasing rates of antipsychotic use across multiyear developmental categories of childhood to adolescence 28 to early adulthood.", "News Context": "Use of #antipsychotic meds increased among teens &amp; young adults from 2006-2010 but not among kids 12 or younger. ", "Paper Context": "There was a rise in antipsychotic use during childhood that extended into adolescence for females, followed by a plateau and a decline during the transition to early adulthood. This age profile refines earlier reports of steadily increasing rates of antipsychotic use across multiyear developmental categories of childhood to adolescence 28 to early adulthood. 29 A peak in antipsychotic use among males aged 11 to 17 years fits with treatment of conduct problems that commonly occur during adolescence.", "scores": "[4.0, 3.0, 4.0]", "field": "Medicine", "split": "train", "final_score": 3.6666666666666665, "source": "tweets", "News URL": "616285498454183936", "text": "REPORTED FINDING: Use of #antipsychotic meds increased among teens &amp; young adults from 2006-2010 but not among kids 12 or younger. <br>PAPER FINDING: This age profile refines earlier reports of steadily increasing rates of antipsychotic use across multiyear developmental categories of childhood to adolescence 28 to early adulthood.", "displayed_text": "REPORTED FINDING: Use of #antipsychotic meds increased among teens &amp; young adults from 2006-2010 but not among kids 12 or younger. <br>PAPER FINDING: This age profile refines earlier reports of steadily increasing rates of antipsychotic use across multiyear developmental categories of childhood to adolescence 28 to early adulthood."}, "Medicine_tweet_15": {"DOI": "10.1001/jamainternmed.2017.7978", "id": "Medicine_tweet_15", "News Finding": "#PreventingType2 #breastfeeding  @username \u00a0breastfeeding  duration is independently associated with lower incidence of diabetes.\u00a0", "Paper Finding": "This study provides longitudinal biochemical evidence that lactation duration is independently associated with lower incidence of diabetes.", "News Context": "#PreventingType2 #breastfeeding  @username \u00a0breastfeeding  duration is independently associated with lower incidence of diabetes.\u00a0", "Paper Context": "There was no evidence of effect modification by race, GD, or parity. This study provides longitudinal biochemical evidence that lactation duration is independently associated with lower incidence of diabetes. Further investigation is required to elucidate mechanisms that may explain this relationship.", "scores": "[2.0, 5.0, 4.0, 4.0]", "field": "Medicine", "split": "train", "final_score": 3.75, "source": "tweets", "News URL": "985972143929380865", "text": "REPORTED FINDING: #PreventingType2 #breastfeeding  @username \u00a0breastfeeding  duration is independently associated with lower incidence of diabetes.\u00a0<br>PAPER FINDING: This study provides longitudinal biochemical evidence that lactation duration is independently associated with lower incidence of diabetes.", "displayed_text": "REPORTED FINDING: #PreventingType2 #breastfeeding  @username \u00a0breastfeeding  duration is independently associated with lower incidence of diabetes.\u00a0<br>PAPER FINDING: This study provides longitudinal biochemical evidence that lactation duration is independently associated with lower incidence of diabetes."}, "Medicine_tweet_157": {"DOI": "10.1038/s41541-019-0118-4", "id": "Medicine_tweet_157", "News Finding": "So excited about my recent publication in @username on a #VLP vaccine targeting #Alzheimers #publishorperish Check it out here: ", "Paper Finding": "Therefore, we believe that this report provides compelling evidence that a VLP-based immunotherapy approach can be beneficial in preventing tau pathology and could be applicable to diverse human tauopathies, such as Alzheimer's disease (AD), frontotemporal dementia (FTD), traumatic brain injury (TBI), and chronic traumatic encephalopathy (CTE).", "News Context": "So excited about my recent publication in @username on a #VLP vaccine targeting #Alzheimers #publishorperish Check it out here: ", "Paper Context": "Reduction in pathological consequences following this immunotherapy translated into improved cognitive function using well-established measurements of delay-dependent and spatial learning and memory tests. Therefore, we believe that this report provides compelling evidence that a VLP-based immunotherapy approach can be beneficial in preventing tau pathology and could be applicable to diverse human tauopathies, such as Alzheimer's disease (AD), frontotemporal dementia (FTD), traumatic brain injury (TBI), and chronic traumatic encephalopathy (CTE). In one example, pTau peptide (MAPT 9-8 , pS6/ 4) formulated with an adjuvant (Adju-Phos), induced taureactive antibodies, reduced MC1 and PHF1 positive neurons in the brains of TgP301L mice and rescued cognitive function.", "scores": "[3.0, 4.0, 5.0, 5.0, 4.0]", "field": "Medicine", "split": "train", "final_score": 4.2, "source": "tweets", "News URL": "1135613881550745600", "text": "REPORTED FINDING: So excited about my recent publication in @username on a #VLP vaccine targeting #Alzheimers #publishorperish Check it out here: <br>PAPER FINDING: Therefore, we believe that this report provides compelling evidence that a VLP-based immunotherapy approach can be beneficial in preventing tau pathology and could be applicable to diverse human tauopathies, such as Alzheimer's disease (AD), frontotemporal dementia (FTD), traumatic brain injury (TBI), and chronic traumatic encephalopathy (CTE).", "displayed_text": "REPORTED FINDING: So excited about my recent publication in @username on a #VLP vaccine targeting #Alzheimers #publishorperish Check it out here: <br>PAPER FINDING: Therefore, we believe that this report provides compelling evidence that a VLP-based immunotherapy approach can be beneficial in preventing tau pathology and could be applicable to diverse human tauopathies, such as Alzheimer's disease (AD), frontotemporal dementia (FTD), traumatic brain injury (TBI), and chronic traumatic encephalopathy (CTE)."}, "Experience.html": {"id": "Experience.html", "text": "Experience", "displayed_text": "Experience"}, "End.html": {"id": "End.html", "text": "End", "displayed_text": "End"}}